We are a group of students relatively new in the research world. We are currently working on our research assessing the anti-carcinogenic effects of active compounds present in Colocasia esculenta parts in mitigating prostate cancer carcinogenesis. This study aims to utilize the whole Colocasia esculenta plant, extracting and isolating the active compounds present in its roots, leaves, and stem, and assess and compare their anti-carcinogenic effectivity against prostate cancer. Thus, we want to ask experts, preferably taro experts but can be also general experts about chemoprevention and oncology, out there several questions below regarding research design and concerns.
We are willing to hold a video consultation session if possible to address such concerns. Your help is very much appreciated.
Dear John
You are persistently using the word carcinogenesis as a synonim to cancer. As you are a biology student I have to tell you that there are not synonims. A substance is carcinogenetic when it has the ability to induce a cancer.
When you work with an established cancer cell you should not use the word carcinogenesis any more. You study the activity of Taro on prostate cancer cell looking if it produces apoptosis or some other change. What you are doing is studying Taro's cytotoxicity on cancer cells. This is not carcinogenesis.
You better use the adequate vocabulary if you want to be clear.
If you test Taro on a normal pristate cell and a cancer develops you may speak about Taro's carcinogenic effects.
I hope you do not mind these corrections. This will help the reader understand what you are doing.
Kind regards
Tomas
Going back to your original question dihydroartemisin or even the original artemisinin are plant products with a powerfull efect on prostate cancer cells inducing ferroptosis.
- Badges
- Science topic
- Similar topics
- Microbiology
- Assays